Quality of life in patients after vestibular schwannoma surgery - Scorecard - MDSpire

Quality of life in patients after vestibular schwannoma surgery

  • By

  • Jan Lazak

  • Jan Betka

  • Eduard Zverina

  • Ales Vlasak

  • Marketa Bonaventurova

  • Zuzana Balatkova

  • Martin Kana

  • Zdenek Fik

  • January 25, 2024

  • 0 min

Share

Clinical Scorecard: Postoperative Quality of Life in Individuals with Vestibular Schwannoma

At a Glance

CategoryDetail
ConditionVestibular schwannoma (VS), a benign tumor of the eighth cranial nerve
Key MechanismsTumor growth causing hearing impairment, tinnitus, vertigo; surgical removal, radiotherapy, or observation as treatment
Target PopulationPatients with unilateral sporadic vestibular schwannoma undergoing retrosigmoid-suboccipital surgical approach
Care SettingTertiary care hospital setting with multidisciplinary surgical team and neurophysiological monitoring

Key Highlights

  • VS symptoms include hearing loss, tinnitus, vertigo with severity varying individually.
  • Surgical treatment risks include facial nerve injury causing functional and psychological complications.
  • Quality of life is now a primary management criterion due to decreased morbidity and mortality.

Guideline-Based Recommendations

Diagnosis

  • Use imaging modalities for diagnosis and tumor size classification via Koos grading scale.
  • Assess hearing using AAO-HNS guidelines, word recognition score, and pure tone average.
  • Evaluate facial nerve function pre- and postoperatively using House-Brackmann classification.

Management

  • Surgical removal via retrosigmoid-suboccipital approach performed by neurosurgeon and otorhinolaryngologist team.
  • Neurophysiological monitoring of cranial nerve function during surgery.
  • Reconstructive surgery for transected facial nerve when indicated.
  • Offer hearing rehabilitation options postoperatively including CROSS/BiCROSS hearing aids, bone-anchored devices, cochlear or brainstem implants.

Monitoring & Follow-up

  • Assess quality of life preoperatively, 3 months, and 1 year postoperatively using validated questionnaires (WHOQOL-BREF, PANQOL, HDI, DI, HHIA, THI, GAD-7, SDS, FDI, DCS).
  • Monitor facial nerve function and hearing at multiple postoperative time points.
  • Use statistical methods to correlate tumor size with postoperative outcomes.

Risks

  • Postoperative facial nerve injury leading to functional deficits and psychological disorders such as anxiety and depression.
  • Postoperative headaches potentially disabling return to normal life.
  • Unilateral sensorineural hearing loss impacting overall quality of life.

Patient & Prescribing Data

Patients with unilateral sporadic vestibular schwannoma undergoing retrosigmoid-suboccipital surgery

Despite availability and safety of hearing compensation devices, relatively few patients utilize them postoperatively.

Clinical Best Practices

  • Employ multidisciplinary surgical teams with intraoperative neurophysiological monitoring to minimize nerve injury.
  • Use validated, multidimensional quality of life assessments to guide postoperative care.
  • Provide comprehensive rehabilitation options including hearing aids and reconstructive surgery when needed.
  • Correlate tumor size with functional outcomes to inform prognosis and patient counseling.

References

Original Source(s)

Related Content